MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1371/journal.pone.0321380

Медицинская библиотека · PloS one · 2025

Mendelian randomization study showed no causality between metformin treatment and polycystic ovary syndrome.

Lin Liting, Shen Huan, Wang Yanbin

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Despite previous clinical studies providing some evidence of an association between metformin treatment and polycystic ovary syndrome(PCOS), these findings remain controversial. To investigate whether the association reflect causality, a two-sample Mendelian randomization (MR) method was conducted.

METHODS

Data from genome-wide association studies were analyzed, with the exposure factor being metformin and the outcome variable being PCOS. The inverse variance weighted(IVW) was used as the primary method for MR analysis. In addition, MR-Egger, weighted median, heterogeneity tests, and sensitivity analyses were performed.

RESULTS

The initial and validation MR analyses indicated that genetically predicted metformin treatment had no effects on PCOS. Sensitivity analyses provided additional confirmation of the reliability of the MR results.

CONCLUSIONS

Our two-sample MR analysis did not find genetic evidence supporting a significant association between metformin treatment and PCOS.

Для цитирования: Lin Liting, Shen Huan, Wang Yanbin. Mendelian randomization study showed no causality between metformin treatment and polycystic ovary syndrome.. PloS one. 2025. DOI: 10.1371/journal.pone.0321380.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.